Journal of Biological Chemistry · 2006 · 103 citations · 28 references
Life SciencesMolecular BiologyNeurobiologyMolecular NeurobiologyMolecular NeuroscienceNeurodegenerationApoptosis In NeurodegenerationHuntington DiseaseNeurodegenerative DiseasesNeurodegenerative DisordersProtein AggregationProtein Aggregation DisordersAggregationHuntingtin AggregationHuntington's Disease ModelsInclusion Body FormationPolyglutamine DiseasesPolyglutamine Expansion DisordersProtein Aggregation InhibitionProtein Aggregation Inhibitors
Several neurodegenerative diseases, including Huntington disease (HD), are associated with aberrant folding and aggregation of polyglutamine (polyQ) expansion proteins. Here we established the zebrafish, Danio rerio, as a vertebrate HD model permitting the screening for chemical suppressors of polyQ aggregation and toxicity. Upon expression in zebrafish embryos, polyQ-expanded fragments of huntingtin (htt) accumulated in large SDS-insoluble inclusions, reproducing a key feature of HD pathology. Real time monitoring of inclusion formation in the living zebrafish indicated that inclusions grow by rapid incorporation of soluble htt species. Expression of mutant htt increased the frequency of embryos with abnormal morphology and the occurrence of apoptosis. Strikingly, apoptotic cells were largely devoid of visible aggregates, suggesting that soluble oligomeric precursors may instead be responsible for toxicity. As in nonvertebrate polyQ disease models, the molecular chaperones, Hsp40 and Hsp70, suppressed both polyQ aggregation and toxicity. Using the newly established zebrafish model, two compounds of the N′-benzylidene-benzohydrazide class directed against mammalian prion proved to be potent inhibitors of polyQ aggregation, consistent with a common structural mechanism of aggregation for prion and polyQ disease proteins. Several neurodegenerative diseases, including Huntington disease (HD), are associated with aberrant folding and aggregation of polyglutamine (polyQ) expansion proteins. Here we established the zebrafish, Danio rerio, as a vertebrate HD model permitting the screening for chemical suppressors of polyQ aggregation and toxicity. Upon expression in zebrafish embryos, polyQ-expanded fragments of huntingtin (htt) accumulated in large SDS-insoluble inclusions, reproducing a key feature of HD pathology. Real time monitoring of inclusion formation in the living zebrafish indicated that inclusions grow by rapid incorporation of soluble htt species. Expression of mutant htt increased the frequency of embryos with abnormal morphology and the occurrence of apoptosis. Strikingly, apoptotic cells were largely devoid of visible aggregates, suggesting that soluble oligomeric precursors may instead be responsible for toxicity. As in nonvertebrate polyQ disease models, the molecular chaperones, Hsp40 and Hsp70, suppressed both polyQ aggregation and toxicity. Using the newly established zebrafish model, two compounds of the N′-benzylidene-benzohydrazide class directed against mammalian prion proved to be potent inhibitors of polyQ aggregation, consistent with a common structural mechanism of aggregation for prion and polyQ disease proteins. A common feature of neurodegenerative diseases, such as Parkinson disease, Alzheimer disease, and polyglutamine (polyQ) 3The abbreviations used are: polyQ, polyglutamine; HD, Huntington disease; NBB, N′-benzylidene-benzohydrazide; htt, huntingtin; GFP, green fluorescent protein; YFP, yellow fluorescent protein; HA, hemagglutinin. diseases, including Huntington disease (HD), is the accumulation and deposition of characteristic amyloid or amyloid-like fibrils of the respective disease proteins in the brain (1Ross C.A. Poirier M.A. Nat. Rev. Mol. Cell. Biol. 2005; 6: 891-898Crossref PubMed Scopus (515) Google Scholar, 2Aguzzi A. Haass C. Science. 2003; 302: 814-818Crossref PubMed Scopus (203) Google Scholar). In HD, it is the intracellular deposition of inclusion bodies that is associated with the degeneration of neurons, primarily in the striatum region of the brain. These inclusion bodies contain fibrillar aggregates of the disease protein, huntingtin (htt), and likely represent the final manifestation of a multi-step aggregation pathway involving several intermediate species (3Poirier M.A. Li H. Macosko J. Cai S. Amzel M. Ross C.A. J. Biol. Chem. 2002; 277: 41032-41037Abstract Full Text Full Text PDF PubMed Scopus (315) Google Scholar). The pathogenic length of the polyQ stretch within the N-terminal segment of htt is ∼38Q or greater, and correlates with its ability to form detergent-insoluble fibrillar aggregates (4Davies S.W. Turmaine M. Cozens B.A. DiFiglia M. Sharp A.H. Ross C.A. Scherzinger E. Wanker E.E. Mangiarini L. Bates G.P. Cell. 1997; 90: 537-548Abstract Full Text Full Text PDF PubMed Scopus (1918) Google Scholar, 5DiFiglia M. Sapp E. Chase K.O. Davies S.W. Bates G.P. Vonsattel J.P. Aronin N. Science. 1997; 277: 1990-1993Crossref PubMed Scopus (2331) Google Scholar, 6Scherzinger E. Lurz R. Turmaine M. Mangiarini L. Hollenbach B. Hasenbank R. Bates G.P. Davies S.W. Lehrach H. Wanker E.E. Cell. 1997; 90: 549-558Abstract Full Text Full Text PDF PubMed Scopus (1090) Google Scholar). N-terminal fragments containing the pathogenic polyQ stretch have been detected in inclusions in HD brain tissue, and their generation is considered to be a critical step in both fibril formation and toxicity (4Davies S.W. Turmaine M. Cozens B.A. DiFiglia M. Sharp A.H. Ross C.A. Scherzinger E. Wanker E.E. Mangiarini L. Bates G.P. Cell. 1997; 90: 537-548Abstract Full Text Full Text PDF PubMed Scopus (1918) Google Scholar, 7Lunkes A. Lindenberg K.S. Ben-Haiem L. Weber C. Devys D. Land-wehrmeyer G.B. Mandel J.L. Trottier Y. Mol. Cell. 2002; 10: 259-269Abstract Full Text Full Text PDF PubMed Scopus (311) Google Scholar). Molecular dynamics simulations of polyQ fragments suggest that the core structure of a htt fibril is composed of peptides arranged in a triangular β-helical structure (8Stork M. Giese A. Kretzschmar H.A. Tavan P. Biophys. J. 2005; 88: 2442-2451Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar). Such fibrillar structures would grow by the attachment of further coils at the top and bottom ends of the β-helix. Although inclusion bodies are closely associated with neurodegenerative disease, there has been considerable debate about the role of aggregates in pathogenesis. Increasing evidence suggests that inclusion bodies, and the fibrillar aggregates therein, may not represent the primary neurotoxic agent (1Ross C.A. Poirier M.A. Nat. Rev. Mol. Cell. Biol. 2005; 6: 891-898Crossref PubMed Scopus (515) Google Scholar, 9Walsh D.M. Klyubin I. Fadeeva J.V. Cullen W.K. Anwyl R. Wolfe M.S. Rowan M.J. Selkoe D.J. Nature. 2002; 416: 535-539Crossref PubMed Scopus (3721) Google Scholar, 10Cleary J.P. Walsh D.M. Hofmeister J.J. Shankar G.M. Kuskowski M.A. Selkoe D.J. Ashe K.H. Nat. Neurosci. 2005; 8: 79-84Crossref PubMed Scopus (1500) Google Scholar, 11Arrasate M. Mitra S. Schweitzer E.S. Segal M.R. Finkbeiner S. Nature. 2004; 431: 805-810Crossref PubMed Scopus (1627) Google Scholar). Instead, soluble intermediates in the aggregation pathway are likely to be the key toxic species, giving rise to neurodegeneration through various mechanisms including inactivation of essential transcription factors and inhibition of the ubiquitin proteasome system (12Schaffar G. Breuer P. Boteva R. Behrends C. Tzvetkov N. Strippel N. Sakahira H. Siegers K. Hayer-Hartl M. Hartl F.U. Mol. Cell. 2004; 15: 95-105Abstract Full Text Full Text PDF PubMed Scopus (358) Google Scholar, 13Bennett E.J. Bence N.F. Jayakumar R. Kopito R.R. Mol. Cell. 2005; 17: 351-365Abstract Full Text Full Text PDF PubMed Scopus (413) Google Scholar). Much attention has therefore been focused on identifying means to disrupt or alter the polyQ aggregation pathway (14Di Prospero N.A. Fischbeck K.H. Nat. Rev. Genet. 2005; 6: 756-765Crossref PubMed Scopus (125) Google Scholar), and several compounds with anti-aggregation activity have been identified in vitro and in cell-based assays (15Heiser V. Engemann S. Brocker W. Dunkel I. Boeddrich A. Waelter S. Nordhoff E. Lurz R. Schugardt N. Rautenberg S. Herhaus C. Barnickel G. Bottcher H. Lehrach H. Wanker E.E. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 16400-16406Crossref PubMed Scopus (196) Google Scholar, 16Hockly E. Tse J. Barker A.L. Moolman D.L. Beunard J.L. Revington A.P. Holt K. Sunshine S. Moffitt H. Sathasivam K. Woodman B. Wanker E.E. Lowden P.A. Bates G.P. Neurobiol. Dis. 2006; 21: 228-236Crossref PubMed Scopus (74) Google Scholar). We set out to develop a zebrafish HD model system suitable for whole organism validation of candidate compounds identified as aggregation inhibitors in vitro. The zebrafish has several key advantages over other in vivo models of HD. It is a vertebrate organism and contains homologues to many human genes, including the htt gene (17Karlovich C.A. John R.M. Ramirez L. Stainier D.Y. Myers R.M. Gene (Amst.). 1998; 217: 117-125Crossref PubMed Scopus (71) Google Scholar), making it a valuable tool to model human diseases such as HD. Additional important advantages include: the ease and cost efficiency with which in vivo drug tests can be performed; the transparency of zebrafish embryos allowing for visualization of morphological and physiological features in the live embryo; and the aqueous environment of the zebrafish, which facilitates drug administration (18Zon L.I. Peterson R.T. Nat. Rev. Drug Discov. 2005; 4: 35-44Crossref PubMed Scopus (1118) Google Scholar). Importantly, the zebrafish model system allows for the evaluation of drug effectiveness in a whole organism, taking into account the stability and cellular targeting of the tested compound, as well as the assessment of potential side effects of the drug at active concentrations. Here, we describe the characterization of a newly established zebrafish model of HD. Mutant htt expressed in zebrafish embryos accumulated in large SDS-insoluble inclusions, recapitulating a cardinal feature of HD pathology. Mutant htt also increased the frequency of embryos with abnormal morphology and dead embryos, as well as the occurrence of apoptosis. As in nonvertebrate polyQ disease models, the molecular chaperones, Hsp40 and Hsp70, suppressed both polyQ aggregation and toxicity. Using this zebrafish model, two anti-prion compounds of the N′-benzylidene-benzohydrazide class were identified as novel inhibitors of polyQ aggregation, suggesting that polyQ aggregates and prions may share common structural epitopes. We also address, for the first time in a vertebrate model system, the controversial question of whether inclusion bodies of polyQ-expanded htt directly contribute to toxicity. Our observation that the majority of apoptotic cells were devoid of visible inclusions suggests that polyQ toxicity is not primarily caused by insoluble aggregates but is more likely caused by soluble aggregation intermediates. Animal Husbandry—All of the experiments were performed in compliance with the guidelines of the German Council on Animal Care. The zebrafish were maintained, mated, and raised as described (19Mullins M.C. Hammerschmidt M. Haffter P. Nusslein-Volhard C. Curr. Biol. 1994; 4: 189-202Abstract Full Text Full Text PDF PubMed Scopus (631) Google Scholar). The embryos were kept at 28 °C and staged as described (20Kimmel C.B. Ballard W.W. Kimmel S.R. Ullmann B. Schilling T.F. Dev. Dyn. 1995; 203: 253-310Crossref PubMed Scopus (8862) Google Scholar). The wild used for and and were by the or G.P. J. Biol. 2002; PubMed Scopus Google into the and of the of used to a which into and S. K. Nat. Biol. 2002; 4: PubMed Scopus Google into The used for transcription of human a A. the In vitro transcription of of performed with the and the at a of into the of embryos at the first or were performed with and as a or and The embryos were at °C in and the were and the embryos were to their zebrafish embryos were with and in on with The were with a and in the embryos were in of Molecular for at and with apoptotic the embryos were in Molecular for and with a of at of and the were to a the or performed by in A of two or of the region at of and the of cells to the of apoptotic the time of the living zebrafish embryos were in in with and with and were for which the over the of the and the embryos were in and in and by through a and the and the were at °C for with The were at for at °C in the of to of the The and with a the of in the embryos were first and as described Y. 2005; 10: PubMed Scopus Google Scholar). the were at for to the and The with at for and in or The for at with and in as N. J. I. Biophys. 277: PubMed Scopus Google Scholar). The were to °C for and and or to the the of to and the for at Several of and were through a to E. Lurz R. Turmaine M. Mangiarini L. Hollenbach B. Hasenbank R. Bates G.P. Davies S.W. Lehrach H. Wanker E.E. Cell. 1997; 90: 549-558Abstract Full Text Full Text PDF PubMed Scopus (1090) Google Scholar). on the were detected with In the were in and to expression the of or the the and were in and the other compounds were in at the indicated concentrations. the the embryos were into two into with and the indicated of compound, and the other into with as a The to of the through the and were several The embryos were at °C for and were and as described The associated with or embryos set to In vitro aggregation were performed as described (12Schaffar G. Breuer P. Boteva R. Behrends C. Tzvetkov N. Strippel N. Sakahira H. Siegers K. Hayer-Hartl M. Hartl F.U. Mol. Cell. 2004; 15: 95-105Abstract Full Text Full Text PDF PubMed Scopus (358) Google Scholar). were with or (3Poirier M.A. Li H. Macosko J. Cai S. Amzel M. Ross C.A. J. Biol. Chem. 2002; 277: 41032-41037Abstract Full Text Full Text PDF PubMed Scopus (315) Google Scholar), (4Davies S.W. Turmaine M. Cozens B.A. DiFiglia M. Sharp A.H. Ross C.A. Scherzinger E. Wanker E.E. Mangiarini L. Bates G.P. Cell. 1997; 90: 537-548Abstract Full Text Full Text PDF PubMed Scopus (1918) Google Scholar), M. Sapp E. Chase K.O. Davies S.W. Bates G.P. Vonsattel J.P. Aronin N. Science. 1997; 277: 1990-1993Crossref PubMed Scopus (2331) Google Scholar), or the aggregation of in A The were at °C for and by of The of SDS-insoluble aggregates the as described were and of set to as of to a the G.M. R. J. Chem. 1998; Scopus Google Scholar), we the of models for the compounds and to a β-helical model for a polyQ The structural model of a polyQ the of (8Stork M. Giese A. Kretzschmar H.A. Tavan P. Biophys. J. 2005; 88: 2442-2451Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar), a triangular as the structure for polyQ amyloid a of two β-helical polyQ structural of the in were at a of the molecular dynamics which for of the structure with its aqueous environment at and in the The polyQ were for the simulations respective which and to the of the models for the were and were the W. J. Chem. 99: Scopus Google Scholar). within the were through to the of a in the of a that are over the for in the We the with and a of at the polyQ the tool within of the polyQ we the of the compounds the in were performed and by The structures of were for the W. A. K. J. Mol. PubMed Scopus Google Scholar). htt into of SDS-insoluble in Danio first whether we key features of HD in at the first or were with N-terminal of htt containing or to green fluorescent and and proteins were the mutant polyQ-expanded htt protein, accumulated in inclusion aggregates embryos of the indicated that but not the polyQ accumulated in inclusions to the and of embryos at time time that inclusions in by incorporation of soluble in its the and cellular of embryos were to both and in the soluble a of in the SDS-insoluble and be by N. J. I. Biophys. 277: PubMed Scopus Google Scholar). of by established E. Lurz R. Turmaine M. Mangiarini L. Hollenbach B. Hasenbank R. Bates G.P. Davies S.W. Lehrach H. Wanker E.E. Cell. 1997; 90: 549-558Abstract Full Text Full Text PDF PubMed Scopus (1090) Google that but not or large SDS-insoluble aggregates that were by the SDS-insoluble aggregates in D. of the of the embryos or were to and the were by and with in in the of Increasing and of A were by in the and of at of whether the proteins caused we the of embryos or The embryos were as or expression associated with increased of dead or abnormal embryos with or expression of embryos indicated that expression caused increased and of and abnormal in embryos and were also which likely to toxicity caused by proteins A and further that of the apoptotic cells were devoid of visible inclusions, which be more for in the other cells containing inclusions were suggesting that may instead be the toxic agent top apoptotic cells containing were detected bottom that expression of polyQ-expanded htt is toxic to the zebrafish but toxicity is not associated with the of visible and Hsp40 and are to both polyQ aggregation and toxicity G. Hartl F.U. Dev. Biol. 2004; 15: PubMed Scopus Google Scholar). We whether we this important feature by the of the human and Hsp40 on aggregation and toxicity in the zebrafish of Hsp40 and to the of SDS-insoluble aggregates of as by the of were not A and that associated with inclusions of suggesting that the as species. Expression of Hsp40 and the of inclusions of not apoptotic cells of not and dead embryos the of embryos aggregation and toxicity associated with expression in zebrafish is suppressed by Hsp40 and of tested the of several of compounds on the aggregation of in the zebrafish we the of inhibitors of the polyQ aggregation to aggregation in this vertebrate and E. Tse J. Barker A.L. Moolman D.L. Beunard J.L. Revington A.P. Holt K. Sunshine S. Moffitt H. Sathasivam K. Woodman B. Wanker E.E. Lowden P.A. Bates G.P. Neurobiol. Dis. 2006; 21: 228-236Crossref PubMed Scopus (74) Google Scholar, I. C. J. Nature. 2003; PubMed Scopus Google aggregation in zebrafish, as by the In not alter aggregation in the zebrafish consistent with a in a model W. S. H. M. Ross C.A. Neurobiol. Dis. 2005; PubMed Scopus Google Scholar). a to htt inclusion formation in W. S. H. M. Ross C.A. Neurobiol. Dis. 2005; PubMed Scopus Google Scholar), on aggregation in zebrafish at the in the of and in other HD in to in W. S. H. M. Ross C.A. Neurobiol. Dis. 2005; PubMed Scopus Google Scholar), suggest that is not of polyQ aggregation in the vertebrate aggregation in vitro and in D. of the indicated chemical compounds on aggregation in as by the with The the containing set to The are the of experiments of embryos in the and of the indicated were for with or or of embryos were the by The to set to The are the of we set out to compounds that polyQ the that polyQ and aggregates have amyloid core structures (8Stork M. Giese A. Kretzschmar H.A. Tavan P. Biophys. J. 2005; 88: 2442-2451Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar, C. H. Proc. Natl. Acad. Sci. U. S. A. 2004; PubMed Scopus Google Scholar), we tested compounds and that were identified in in vitro for inhibitors of prion U. J. Weber P. Hartl F.U. Tavan P. J. Kretzschmar H.A. Giese A. J. 2005; PubMed Scopus Google Scholar). of compounds the aggregation of polyQ-expanded htt in vitro that compounds directly with mutant htt to its and both of N′-benzylidene-benzohydrazide also the formation of detergent-insoluble aggregates of in vivo a more of polyQ aggregation in vivo but not in vitro the of on polyQ aggregation, we set a model of HD in mammalian cells In this system, expression of but not or in the formation of inclusions containing SDS-insoluble not toxic to cells the tested with the the zebrafish system, proved in aggregation in cells suggest that represent a class of compounds that polyQ of the compounds suppressed the abnormal morphology and associated with expression in zebrafish embryos not the may with the formation of large polyQ aggregates of the accumulation of toxic polyQ species. into the effects of the anti-prion compounds on polyQ aggregation, we their to a structural model for a polyQ (8Stork M. Giese A. Kretzschmar H.A. Tavan P. Biophys. J. 2005; 88: 2442-2451Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar). The simulations large in a and for of the As in for the with of the compounds were to to the two ends of the polyQ are for the two compounds and both of which for attachment to the polyQ The of and a of the compounds a of further with the In simulations a polyQ model that to the ends of the polyQ a mechanism that would fibril other structural models for polyQ R. D. Curr. Biol. 2006; PubMed Scopus Google Scholar), but are by attachment and at the ends of which We set out to develop a zebrafish HD model system suitable for whole organism validation of candidate The zebrafish model of HD described in this allows the deposition of htt aggregates to be in time in a living vertebrate Expression of polyQ-expanded htt rise to the formation of SDS-insoluble inclusions and associated with as well as morphological and of zebrafish the abnormal embryos, a characteristic in embryos not mutant is by of the a in the P. U. Nature. 1998; PubMed Scopus Google and has been to be associated with in of the in zebrafish R. Dev. 2004; PubMed Scopus Google Scholar). The of the may therefore of on is to be in HD I. M.R. Biophys. 2004; PubMed Scopus Google Scholar). important observation that both the aggregation and toxicity of mutant htt suppressed by the molecular chaperones, Hsp40 and Hsp70, other HD models G. Hartl F.U. Dev. Biol. 2004; 15: PubMed Scopus Google Scholar). key features of HD are in zebrafish model, we that zebrafish is a model organism for identifying factors that disease pathogenesis. The newly established zebrafish model proved in the effectiveness of compounds in polyQ aggregation and toxicity in the of a whole vertebrate Drug into the zebrafish is likely by its aqueous environment and of brain at in compounds be tested for their on polyQ aggregation factors that The feature that drug can be performed within this model a and to models of HD. The ability to the effects on aggregation toxicity is of the zebrafish system, which is in several other HD models, such as the model tested in this The zebrafish model also into account the stability and the cellular targeting of compounds in of the tested in polyQ aggregation in vitro but not as aggregation in vivo suggesting that this is not not in the Using zebrafish, we were also to whether a caused side effects at active in a whole a to htt inclusion formation in caused in the brain region of the zebrafish at not and on polyQ aggregation at the We used the newly established zebrafish model to as inhibitors of polyQ of the anti-prion and were identified as inhibitors of the of prion into aggregates U. J. Weber P. Hartl F.U. Tavan P. J. Kretzschmar H.A. Giese A. J. 2005; PubMed Scopus Google Scholar), has been in a and mutant htt are neurodegenerative disease proteins that in fibrillar aggregates that may have a common β-helical amyloid core structure (8Stork M. Giese A. Kretzschmar H.A. Tavan P. Biophys. J. 2005; 88: 2442-2451Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar, C. H. Proc. Natl. Acad. Sci. U. S. A. 2004; PubMed Scopus Google Scholar). We therefore that inhibitors of the aggregation of may also be in polyQ Our observation that anti-prion compounds are potent inhibitors of polyQ aggregation suggests that polyQ aggregates and prions share common structural epitopes. model of HD zebrafish and further established the zebrafish system as a model to human the that common mechanisms the of neurodegenerative diseases and suggest that common may on may a class of compounds with anti-aggregation the and aggregation of a of neurodegenerative disease proteins. a novel and structure for the of in several The used in this of for by a molecular and a which would or C.A. Drug Rev. PubMed Scopus Google Scholar). Importantly, that in a vertebrate organism, can the in active toxic side effects to the of their in that the of the which were to be for anti-prion activity in vitro U. J. Weber P. Hartl F.U. Tavan P. J. Kretzschmar H.A. Giese A. J. 2005; PubMed Scopus Google Scholar), are not essential for inhibition of polyQ aggregation in the in a of polyQ aggregation in vivo and the of a by the to and the to such as may be that are more likely to the the of aggregation inhibitors in aggregation diseases also on the of the toxic species and whether toxicity primarily through a or of that with formation at the molecular such as the may valuable to further the molecular in disease in The zebrafish model has also to the question of whether inclusions of polyQ-expanded htt contribute directly to toxicity in a vertebrate Our observation that the majority of apoptotic cells were devoid of visible inclusions suggests that polyQ toxicity is not primarily caused by inclusions, in with in M. Mitra S. Schweitzer E.S. Segal M.R. Finkbeiner S. Nature. 2004; 431: 805-810Crossref PubMed Scopus (1627) Google Scholar, G. Breuer P. Boteva R. Behrends C. Tzvetkov N. Strippel N. Sakahira H. Siegers K. Hayer-Hartl M. Hartl F.U. Mol. Cell. 2004; 15: 95-105Abstract Full Text Full Text PDF PubMed Scopus (358) Google Scholar). with a of which would are therefore in toxicity in may the formation of SDS-insoluble aggregates polyQ toxicity and not We that primarily of soluble intermediates in the htt aggregation pathway associated with toxicity may at structural of may to the of more suppressors of polyQ toxicity. to compounds that aggregation in vitro or in A for such candidate compounds the of vertebrate model to against polyQ aggregation and toxicity to and drug the zebrafish model described is likely to for this We A. M. for and C. for the for with A. for the and M. for the with
28
VMD: Visual molecular dynamics
William Humphrey, Andrew Dalke, Klaus Schulten · Journal of Molecular Graphics · 1996 · 66.6K citations
Stages of embryonic development of the zebrafish
Charles B. Kimmel, William W. Ballard, Seth R. Kimmel et al. · Developmental Dynamics · 1995 · 12.3K citations